Amyotrophic lateral sclerosis: Problems and prospects

Annals of Neurology - Tập 74 Số 3 - Trang 309-316 - 2013
Jemeen Sreedharan1,2,3, Robert H. Brown3
1Babraham Institute, Cambridge, United Kingdom
2Department of Neurobiology, University of Massachusetts Medical School, Worcester, MA
3Department of Neurology, University of Massachusetts Medical School, Worcester, MA

Tóm tắt

Amyotrophic lateral sclerosis (ALS) is a lethal degenerative disorder of motoneurons, which may occur concurrently with frontotemporal dementia. Genetic analyses of the ∼10% of ALS cases that are dominantly inherited provide insight into ALS pathobiology. Two broad themes are evident. One, prompted by investigations of the SOD1 gene, is that conformational instability of proteins triggers downstream neurotoxic processes. The second, from studies of the TDP43, FUS, and C9orf72 genes, is that perturbations of RNA processing can be highly adverse in motoneurons. Several investigations support the concept that non‐neuronal cells (microglia, astroglia, oligodendroglia) participate in the degenerative process in ALS. Recent data also emphasize the importance of molecular events in the axon and distal motoneuron terminals. Only 1 compound, riluzole, is approved by the US Food and Drug Administration for ALS; several therapies are in clinical trials, including 2 mesenchymal stem cell trials. The challenges and unmet needs in ALS emphasize the importance of new research directions: high‐throughput sequencing of large DNA sets of familial and sporadic ALS, which will define scores of candidate ALS genes and pathways and facilitate studies of epistasis and epigenetics; infrastructures for candidate gene validation, including in vitro and in vivo modeling; valid biomarkers that elucidate causative molecular events and accelerate clinical trials; and in the long term, methods to identify environmental toxins. The unprecedented intensity of research in ALS and the advent of extraordinary technologies (rapid, inexpensive DNA sequencing; stem cell production from skin‐derived fibroblasts; silencing of miscreant mutant genes) bode well for discovery of innovative ALS therapies. Ann Neurol 2013;74:309–316

Từ khóa


Tài liệu tham khảo

10.1007/s00415-006-0195-y

10.1002/humu.22157

10.1038/362059a0

10.1126/science.8209258

10.1093/hmg/dds188

10.1073/pnas.1017275108

10.1038/ng1001-166

10.1038/ng1001-160

10.1086/301769

10.1038/ng1123

10.1086/425287

10.1126/science.1134108

10.1016/j.bbrc.2006.10.093

10.1126/science.1154584

10.1038/ng.132

10.2741/2727

10.1093/hmg/dds205

10.1371/journal.pgen.1000193

10.1073/pnas.1008227107

10.1074/jbc.M112.433615

10.1038/emboj.2010.310

10.1007/s00401-009-0571-7

10.1093/hmg/ddq230

10.1371/journal.pone.0012247

10.1093/hmg/ddt005

10.1093/hmg/ddp534

10.1016/j.pnpbp.2010.08.006

10.1093/brain/awr159

10.1007/s00401-012-0979-3

10.1371/journal.pgen.1000887

10.1126/science.1166066

10.1126/science.1165942

10.1093/hmg/ddq335

10.1016/j.brainres.2012.01.016

10.1016/j.celrep.2013.06.007

10.1093/brain/awl030

10.1212/01.wnl.0000200048.53766.b4

10.1038/ng.442

10.1016/S1474-4422(10)70197-6

10.1016/j.neuron.2011.09.010

10.1016/j.neuron.2011.09.011

10.1016/j.ajhg.2013.01.011

10.1038/ejhg.2012.98

10.1016/j.neulet.2007.03.066

10.1073/pnas.1109434108

Ciura S, Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis, Ann Neurol

10.1038/srep01016

10.1007/s00401-013-1088-7

10.1073/pnas.1013343108

10.1126/science.1232927

10.1016/j.neuron.2013.02.004

10.1016/j.expneurol.2003.10.004

10.1007/s004010050535

10.1136/jnnp.2009.194399

10.1007/BF00308929

10.1136/jnnp.2010.236018

10.1007/s00401-010-0683-0

10.1002/ana.23937

10.1038/nn1653

10.1038/nature11280

10.1038/nm.2901

10.1212/WNL.37.5.738

10.1093/hmg/ddm226

10.1073/pnas.1303279110

10.1146/annurev-neuro-060909-153248

10.1371/journal.pbio.1001539

10.1126/science.1223899

10.1371/journal.pbio.1001440

10.1073/pnas.0812937106

10.1016/j.neurobiolaging.2012.07.017

10.1073/pnas.0902174106

10.1126/science.1123511

10.1038/nn1876

10.1073/pnas.0802556105

10.1038/nn.3357

10.1038/emboj.2013.122

10.1038/nature11314

Miller RG, 2012, Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), Cochrane Database Syst Rev, 3, CD001447

10.1016/S1474-4422(13)70061-9

Thông tin
Thông tin xuất bản

Annals of Neurology

Tập 74 Số 3

309-316

Thông tin tác giả